Bench to Bedside: Tebentafusp, the Story of the First Approved TCR Therapeutic
Time: 9:00 am
day: Conference Day 1
Details:
- A historical overview exploring the context of building a novel pipeline and platform
- Developing and characterizing transformative medicines to address unmet needs in cancer
